Page last updated: 2024-08-23

castanospermine and Dengue

castanospermine has been researched along with Dengue in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gahan, ME; Keller, PA; Mahalingam, S; Stevens, AJ	1
Behnam, MA; Boldescu, V; Klein, CD; Nitsche, C	1
Aw, P; Chan, KW; Choy, MM; Connolly, JE; de Sessions, PF; Fan, L; Hibberd, ML; Kamaraj, US; Khoo, YM; Lee, B; Lee, HS; Low, JG; Ooi, EE; Rathore, AP; Sessions, OM; Sung, C; Vasudevan, SG; Vijaykrishna, D; Watanabe, S; Wei, Y; Wijaya, L	1
Connolly, J; Khoo, YM; Lee, HS; Low, J; Lu, F; Ooi, EE; Rathore, AP; Sung, C; Vasudevan, SG; Watanabe, S	1
Diamond, MS; Doms, RW; Engle, M; Geiss, B; Lane, K; Pierson, TC; Whitby, K; Zhou, Y	1
Courageot, MP; Desprès, P; Deubel, V; Dos Santos, CD; Frenkiel, MP	1

Reviews

2 review(s) available for castanospermine and Dengue

Article	Year
The medicinal chemistry of dengue fever. Journal of medicinal chemistry, 2009, Dec-24, Volume: 52, Issue:24 Topics: Antiviral Agents; Dengue; Dengue Virus; Humans; Models, Molecular; Viral Proteins	2009
The Medicinal Chemistry of Dengue Virus. Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12 Topics: Antiviral Agents; Chemistry, Pharmaceutical; Dengue; Dengue Virus; Humans; Molecular Conformation; Structure-Activity Relationship	2016

Trials

1 trial(s) available for castanospermine and Dengue

Article	Year
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:8 Topics: Adult; Antiviral Agents; Cytokines; Dengue; Dengue Virus; Female; Half-Life; High-Throughput Nucleotide Sequencing; Humans; Indolizines; Male; Phylogeny; Th1 Cells; Viral Load; Viremia; Virus Replication	2016

Article

Year

Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

PLoS neglected tropical diseases, 2016, Volume: 10, Issue:8

Topics: Adult; Antiviral Agents; Cytokines; Dengue; Dengue Virus; Female; Half-Life; High-Throughput Nucleotide Sequencing; Humans; Indolizines; Male; Phylogeny; Th1 Cells; Viral Load; Viremia; Virus Replication

2016

Other Studies

3 other study(ies) available for castanospermine and Dengue

Article	Year
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. Antiviral research, 2012, Volume: 96, Issue:1 Topics: Animals; Antiviral Agents; Dengue; Dengue Virus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy; Indolizines; Mice; Survival Analysis	2012
Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. Journal of virology, 2005, Volume: 79, Issue:14 Topics: Animals; Antiviral Agents; Dengue; Dengue Virus; Indolizines; Mice; Mice, Inbred C57BL; RNA, Viral; Virion; West Nile Fever; West Nile virus; Yellow fever virus	2005
Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. Journal of virology, 2000, Volume: 74, Issue:1 Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Amino Acid Sequence; Animals; Dengue; Dengue Virus; Endoplasmic Reticulum; Enzyme Inhibitors; Indolizines; Mice; Molecular Sequence Data; Protein Processing, Post-Translational; Viral Structural Proteins; Virion; Virus Replication	2000